Lee Jennifer Kayden (CIK 1801372) reported 5 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-14). Recent activity: Buy RYTM (35,000 shares), Buy RYTM (21,601 shares), Sell RYTM (75,834 shares), Buy RYTM (22,612 shares), Sell RYTM (9,237 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-14 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of North America | Buy | 35,000 | $850,150 |
| 2026-08-14 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of North America | Buy | 21,601 | $146,887 |
| 2026-08-14 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of North America | Sell | 75,834 | $8.9M |
| 2026-02-03 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of North America | Buy | 22,612 | $0 |
| 2026-02-03 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of North America | Sell | 9,237 | $1.0M |
Source: SEC Form 4 filings · as of 2026-08-14